uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Lack of relationship between systemic exposure for the component drug ofthe fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen inbreast cancer patients.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. (Farmakokinetik)
Uppsala University, Medicinska vetenskapsområdet, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. (Pharmacokinetics and Drug Therapy)
Faculty of Medicine, Department of Medical Sciences. (Klinisk farmakologi, R Larsson)
Department of Oncology, Radiology and Clinical Immunology.
Show others and affiliations
1996 (English)In: J Clin Oncol, Vol. 14, 1581- p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
1996. Vol. 14, 1581- p.
Identifiers
URN: urn:nbn:se:uu:diva-50592OAI: oai:DiVA.org:uu-50592DiVA: diva2:78500
Available from: 2008-10-17 Created: 2008-10-17 Last updated: 2011-01-15

Open Access in DiVA

No full text

By organisation
Department of Pharmaceutical BiosciencesDepartment of Medical SciencesDepartment of Oncology, Radiology and Clinical Immunology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 324 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf